|
1
|
Levey AS, Eckardt KU, Tsukamoto Y, Levin
A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N and
Eknoyan G: Definition and classification of chronic kidney disease:
A position statement from Kidney Disease: Improving Global Outcomes
(KDIGO). Kidney Int. 67:2089–2100. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parrish AR: Advances in chronic kidney
disease. Int J Mol Sci. 17:13142016. View Article : Google Scholar
|
|
3
|
Webster AC, Nagler EV, Morton RL and
Masson P: Chronic kidney disease. Lancet. 389:1238–1252. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wilkinson TJ, Shur NF and Smith AC:
‘Exercise as medicine’ in chronic kidney disease. Scand J Med Sci
Sports. 26:985–988. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li X, Bayliss G and Zhuang S: Cholesterol
crystal embolism and chronic kidney disease. Int J Mol Sci.
18:11202017. View Article : Google Scholar
|
|
6
|
Humphreys BD: Mechanisms of renal
fibrosis. Annu Rev Physiol. 80:309–326. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li R, Guo Y, Zhang Y, Zhang X, Zhu L and
Yan T: Salidroside ameliorates renal interstitial fibrosis by
inhibiting the TLR4/NF-κB and MAPK signaling pathways. Int J Mol
Sci. 20:11032019. View Article : Google Scholar
|
|
8
|
Xie XS, Yang M, Liu HC, Zuo C, Li Z, Deng
Y and Fan JM: Influence of ginsenoside Rg1, a panaxatriol saponin
from Panax notoginseng, on renal fibrosis in rats with unilateral
ureteral obstruction. J Zhejiang Univ Sci B. 9:885–894. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li JH, Wang W, Huang XR, Oldfield M,
Schmidt AM, Cooper ME and Lan HY: Advanced glycation end products
induce tubular epithelial-myofibroblast transition through the
RAGE-ERK1/2 MAP kinase signaling pathway. Am J Pathol.
164:1389–1397. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu JH, He L, Zou ZM, Ding ZC, Zhang X,
Wang H, Zhou P, Xie L, Xing S and Yi CZ: A novel inhibitor of
homodimerization targeting MyD88 ameliorates renal interstitial
fibrosis by counteracting TGF-β1-induced EMT in vivo and in vitro.
Kidney Blood Press Res. 43:1677–1687. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Waisberg J, Theodoro TR, Matos LL, Orlandi
FB, Serrano RL, Saba GT and Pinhal MA: Immunohistochemical
expression of heparanase isoforms and syndecan-1 proteins in
colorectal adenomas. Eur J Histochem. 60:25902016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Palaiologou M, Delladetsima I and Tiniakos
D: CD138 (syndecan-1) expression in health and disease. Histol
Histopathol. 29:177–189. 2014.PubMed/NCBI
|
|
13
|
Masola V, Bellin G, Gambaro G and Onisto
M: Heparanase: A multitasking protein involved in extracellular
matrix (ECM) remodeling and intracellular events. Cells. 7:2362018.
View Article : Google Scholar
|
|
14
|
Jiao W, Chen Y, Song H, Li D, Mei H, Yang
F, Fang E, Wang X, Huang K, Zheng L and Tong Q: HPSE enhancer RNA
promotes cancer progression through driving chromatin looping and
regulating hnRNPU/p300/EGR1/HPSE axis. Oncogene. 37:2728–2745.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lorente-Gea L, Garcia B, Martin C, Quiros
LM and Fernandez-Vega I: Heparan sulfate proteoglycans and
heparanases in Alzheimer's disease: Current outlook and potential
therapeutic targets. Neural Regen Res. 12:914–915. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Masola V, Zaza G, Onisto M, Lupo A and
Gambaro G: Impact of heparanase on renal fibrosis. J Transl Med.
13:1812015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shu T, Pang M, Rong L, Liu C, Wang J, Zhou
W, Wang X and Liu B: Protective effects and mechanisms of
salvianolic acid B against H2O2-induced
injury in induced pluripotent stem cell- derived neural stem cells.
Neurochem Res. 40:1133–1143. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin C, Liu Z, Lu Y, Yao Y, Zhang Y, Ma Z,
Kuai M, Sun X, Sun S, Jing Y, et al: Cardioprotective effect of
Salvianolic acid B on acute myocardial infarction by promoting
autophagy and neovascularization and inhibiting apoptosis. J Pharm
Pharmacol. 68:941–952. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Katary MA, Abdelsayed R, Alhashim A,
Abdelhasib M and Elmarakby AA: Salvianolic acid B slows the
progression of breast cancer cell growth via enhancement of
apoptosis and reduction of oxidative stress, inflammation, and
angiogenesis. Int J Mol Sci. 20:56532019. View Article : Google Scholar
|
|
20
|
Wang B, Sun J, Shi Y and Le G: Salvianolic
acid B inhibits high-fat diet-induced inflammation by activating
the Nrf2 pathway. J Food Sci. 82:1953–1960. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang QL, Tao YY, Yuan JL, Shen L and Liu
CH: Salvianolic acid B prevents epithelial-to-mesenchymal
transition through the TGF-beta1 signal transduction pathway in
vivo and in vitro. BMC Cell Biol. 11:312010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu Y, Li Q, Pan Y and Xu L: Sal B
alleviates myocardial ischemic injury by inhibiting TLR4 and the
priming phase of NLRP3 inflammasome. Molecules. 24:44162019.
View Article : Google Scholar
|
|
23
|
Schwalm S, Beyer S, Frey H, Haceni R,
Grammatikos G, Thomas D, Geisslinger G, Schaefer L, Huwiler A and
Pfeilschifter J: Sphingosine kinase-2 deficiency ameliorates kidney
fibrosis by up-regulating smad7 in a mouse model of unilateral
ureteral obstruction. Am J Pathol. 187:2413–2429. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yao Y, Zhang J, Tan DQ, Chen XY, Ye DF,
Peng JP, Li JT, Zheng YQ, Fang L, Li YK and Fan MX: Interferon-γ
improves renal interstitial fibrosis and decreases intrarenal
vascular resistance of hydronephrosis in an animal model. Urology.
77:761.e8–e13. 2011. View Article : Google Scholar
|
|
25
|
Dou F, Liu Y, Liu L, Wang J, Sun T, Mu F,
Guo Q, Guo C, Jia N, Liu W, et al: Aloe-emodin ameliorates renal
fibrosis via inhibiting PI3K/Akt/mTOR signaling pathway in vivo and
in vitro. Rejuvenation Res. 22:218–229. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Masola V, Zaza G, Granata S, Gambaro G,
Onisto M and Lupo A: Everolimus-induced epithelial to mesenchymal
transition in immortalized human renal proximal tubular epithelial
cells: Key role of heparanase. J Transl Med. 11:2922013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Masola V, Gambaro G, Tibaldi E, Brunati
AM, Gastaldello A, D'Angelo A, Onisto M and Lupo A: Heparanase and
syndecan-1 interplay orchestrates fibroblast growth
factor-2-induced epithelial-mesenchymal transition in renal tubular
cells. J Biol Chem. 287:1478–1488. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Takahashi M, Takayama S, Suga H, Kadomura
S, Kojima M, Iwao K, Takeda K, Sato H, Kobayashi M and Saitoh H:
Factors resulting correlation and differences in renal function
evaluation index using the serum cystatin c and creatinine as
measured by an enzymatic method. Yakugaku Zasshi. 140:81–90.
2020.(In Japanese). View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun YB, Qu X, Caruana G and Li J: The
origin of renal fibroblasts/myofibroblasts and the signals that
trigger fibrosis. Differentiation. 92:102–107. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang HY, Zhang C, Xiao QF, Dou HC, Chen Y,
Gu CM and Cui MJ: Hepatocyte growth factor inhibits tubular
epithelial-myofibroblast transdifferentiation by suppression of
angiotensin II via the JAK2/STAT3 signaling pathway. Mol Med Rep.
15:2737–2743. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li X, Li X, Zhang Q and Zhao T: Low
molecular weight fucoidan and its fractions inhibit renal
epithelial mesenchymal transition induced by TGF-β1 or FGF-2. Int J
Biol Macromol. 105:1482–1490. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yuan Q, Tan RJ and Liu Y: Myofibroblast in
kidney fibrosis: Origin, activation, and regulation. Adv Exp Med
Biol. 1165:253–283. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu M, Ning X, Li R, Yang Z, Yang X, Sun S
and Qian Q: Signalling pathways involved in hypoxia-induced renal
fibrosis. J Cell Mol Med. 21:1248–1259. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yu X, Xia Y, Zeng L, Zhang X, Chen L, Yan
S, Zhang R, Zhao C, Zeng Z, Shu Y, et al: A blockade of PI3Kγ
signaling effectively mitigates angiotensin II-induced renal injury
and fibrosis in a mouse model. Sci Rep. 8:109882018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fujimura K, Wakino S, Minakuchi H,
Hasegawa K, Hosoya K, Komatsu M, Kaneko Y, Shinozuka K, Washida N,
Kanda T, et al: Ghrelin protects against renal damages induced by
angiotensin-II via an antioxidative stress mechanism in mice. PLoS
One. 9:e943732014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Thakur S, Viswanadhapalli S, Kopp JB, Shi
Q, Barnes JL, Block K, Gorin Y and Abboud HE: Activation of
AMP-activated protein kinase prevents TGF-β1-induced
epithelial-mesenchymal transition and myofibroblast activation. Am
J Pathol. 185:2168–2180. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rodriguez-Mateo C, Torres B, Gutierrez G
and Pintor-Toro JA: Downregulation of Lnc-Spry1 mediates
TGF-β-induced epithelial-mesenchymal transition by transcriptional
and posttranscriptional regulatory mechanisms. Cell Death Differ.
24:785–797. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Griggs LA, Hassan NT, Malik RS, Griffin
BP, Martinez BA, Elmore LW and Lemmon CA: Fibronectin fibrils
regulate TGF-β1-induced Epithelial-mesenchymal transition. Matrix
Biol 60–61. 157–175. 2017. View Article : Google Scholar
|
|
39
|
Lu HY, Zhou J, Lu M, Liu YM, Wang F, Lin M
and Zhang Y: Protection and mechanisms of salvianolic-acid B on
experimental renal interstitial fibrosis in rats. Zhong Yao Cai.
33:1755–1759. 2010.(In Chinese). PubMed/NCBI
|
|
40
|
Wang QL, Yuan JL, Tao YY, Hu YY and Liu
CH: Effect of salvianolic acid B on renal interstitial fibrosis in
rats induced by HgCl2. Pharmacol Clin Chin Materia Medica.
24:12–15. 2008.
|
|
41
|
Zhou J, Zhang Y, Lu H, Liu Y and Lin M:
Effect of salvianolic acid B on generation and activation of
myofibroblast in rat with renal interstitial fibrosis. Zhongguo
Zhong Yao Za Zhi. 34:2790–2793. 2009.(In Chinese). PubMed/NCBI
|
|
42
|
Motta G and Tersariol ILS: Modulation of
the plasma kallikrein-kinin system proteins performed by heparan
sulfate proteoglycans. Front Physiol. 8:4812017. View Article : Google Scholar : PubMed/NCBI
|
